Carl Zeiss Meditec (OTCMKTS:CZMWY) Stock Rating Lowered by Zacks Research

Carl Zeiss Meditec (OTCMKTS:CZMWY) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Monday,Zacks.com reports.

Separately, Sanford C. Bernstein lowered shares of Carl Zeiss Meditec to a “market perform” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Carl Zeiss Meditec Trading Up 1.2%

Shares of Carl Zeiss Meditec stock opened at $30.72 on Monday. The company has a 50-day moving average of $29.83 and a 200 day moving average of $37.46. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $72.57.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.